Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study. - Wikidata - wikimedia - TriplyDB

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.

http://www.wikidata.org/entity/Q36622073

about

Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs.Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment.Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment.Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study.The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression.New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC.Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case Report.EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer.Circulating DNA in EGFR-mutated lung cancer.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients.Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis.Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy

P2860

Q26741814-1F7E2672-9576-49FB-879C-CB29EF6B4804 Q33621143-DFABF3F5-130B-4143-A571-971A679DF501 Q36085487-85A0EA36-AAF8-4A2F-B172-7D840D648E51 Q36746250-81897B17-FBAA-426E-9D70-E2F172200F59 Q37060387-8735C825-FBA9-4E47-90BD-E14F1B2A2531 Q37565381-0D944C05-45FB-4A03-8593-94F80D7DC775 Q38673986-1763B1DD-2556-4919-AC09-3519B0CEAE2F Q38679628-5709F8DB-0770-4E10-A3DB-6949B17AA652 Q39002233-82D18C21-F01C-4B4A-8013-C52B8F6493A9 Q39007500-12ED5798-4E54-4EFF-9EE6-DA51FF855435 Q39114552-7C3AD912-C4C1-44FA-9A77-CE60637DE3B0 Q40489387-79659F57-D58B-4276-BCFE-DB193511FFC9 Q41601469-E97D2F2C-755E-4ACA-859C-2901CCF662A1 Q45886897-597F3FA2-E6E9-4AAA-8703-0E096F4586B4 Q46917029-2CC6C219-E6E8-42D2-B019-AEEF4E23EDE7 Q47162466-37066636-F40B-4BF0-AA2C-906C27105FFB Q48004444-AF7BD1C4-BED4-4CC9-91DC-31FF636180EB Q48499401-F43EADA9-CEDE-4D79-8128-9D52F6E0A848 Q52723939-8AB2A21C-9D08-4C67-B735-7A6BFF693C93 Q54977581-F37DE4F8-0CE3-45A5-80FA-18A223BB8C40 Q54984377-54185CB3-BCAF-4F0A-8414-E68685628230 Q58776683-CDA83910-A4DB-410B-B31D-724E1DC0D7F5 Q58796919-2CC7C131-7AD5-449A-B78E-4436B74E2397

P2860

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.

http://www.wikidata.org/entity/Q36622073

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Monitoring EGFR T790M with pla ...... ospective observational study.

@ast

Monitoring EGFR T790M with pla ...... ospective observational study.

@en

type

label

Monitoring EGFR T790M with pla ...... ospective observational study.

@ast

Monitoring EGFR T790M with pla ...... ospective observational study.

@en

prefLabel

Monitoring EGFR T790M with pla ...... ospective observational study.

@ast

Monitoring EGFR T790M with pla ...... ospective observational study.

@en

P1433

Q36622073-1C771DB4-7F6C-4893-BFE1-976F1FC4CA0B

P1476

Q36622073-30D1F619-CCD0-43AE-9872-9EF3C053151A

P2093

Q36622073-18F79533-F17B-4550-BCF5-3F5F6C1928CE

Q36622073-1F309237-338F-4904-89A4-5C1901FB8E9F

Q36622073-2333A7BB-74E6-40C4-8D07-D8709F14E0E1

Q36622073-321368C1-A939-4C73-A8A7-2626FEBA11CA

Q36622073-34F82CAB-E58A-45A1-A8B3-E562B9D6F3D2

Q36622073-4A9BD55E-6470-4312-89AD-54B8056E25C8

Q36622073-69D2634E-4325-4D5C-839E-B8FC992E958D

Q36622073-6C6DB1FC-6867-46ED-A592-9C472589F565

Q36622073-C8BBEF8B-E441-47D0-8EF6-E6E16D75CD19

Q36622073-F6D31D06-3AED-438E-81AD-21D7954A8878

P2860

Q36622073-054D1F46-9784-4D22-973B-C3C09645695E

Q36622073-076C406B-ED68-4B9B-B2F8-40D1E40993A3

Q36622073-0ED66C82-3D10-4A54-B8D4-2607F0C34D60

Q36622073-15586E7A-1E54-4B1B-9862-83122A7224B1

Q36622073-22B32A37-39F6-4B29-A1BF-D58837BA2CAC

Q36622073-3A51BE9A-D9AC-447D-808D-16B535226D03

Q36622073-41947D6D-E404-449E-BBB4-31E48AD09A2B

Q36622073-61A46761-A3FB-422B-80DF-88AD0C20219D

Q36622073-61A77C81-6783-4AD2-9C0A-3F16BF07405F

Q36622073-6468C73F-EFF1-40D0-AEFD-9E483D8F66C8

P304

Q36622073-5610E88A-3076-4400-A2A6-50BC8A965D03

P31

Q36622073-52981094-F843-4CCD-9CAE-9CC4700B66BE

P356

Q36622073-5A22EA29-FEDA-4B69-A239-B29210B3E401

P433

Q36622073-D98515F6-1CC9-4DED-A23E-3E38D68929AB

P478

Q36622073-1F5EB147-1FE9-4C7C-AA5D-DE3C9F37544A

P577

Q36622073-A830FA25-D9FC-4B77-9C51-50413BD11A84

P698

Q36622073-F3A37621-B7FD-4A7B-8179-ECEE56C0D973

P932

Q36622073-1ECB316C-45F1-428D-99BA-F507F944543E

P356

P1433

P1476

Monitoring EGFR T790M with pla ...... ospective observational study.

@en

P2093

Hanshin-Saga Collaborative Cancer Study Group

http://www.w3.org/2001/XMLSchema#string

Keisuke Aoe

http://www.w3.org/2001/XMLSchema#string

Kentaro Iwanaga

http://www.w3.org/2001/XMLSchema#string

Kojiro Otsuka

http://www.w3.org/2001/XMLSchema#string

Miyako Satouchi

http://www.w3.org/2001/XMLSchema#string

Naoko Sueoka-Aragane

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Katakami

http://www.w3.org/2001/XMLSchema#string

Satoshi Morita

http://www.w3.org/2001/XMLSchema#string

Shinya Kimura

http://www.w3.org/2001/XMLSchema#string

Shunichi Negoro

http://www.w3.org/2001/XMLSchema#string

P2860

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA

Circulating mutant DNA to assess tumor dynamics

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

P304

162-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12847

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26577492

http://www.w3.org/2001/XMLSchema#string

P932

4768390

http://www.w3.org/2001/XMLSchema#string